These findingssuggest that OCIAD2 promotes cancer progression through metabolicreprogramming, highlighting the role of OCIAD2 as a potential biomarkerand therapeutic target for lung adenocarcinoma. The gene discussed is OCIAD2; the disease is lung adenocarcinoma.